Cargando…

Lectin nanoparticle assays for detecting breast cancer-associated glycovariants of cancer antigen 15-3 (CA15-3) in human plasma

Cancer antigen 15–3 (CA15-3) is widely utilized for monitoring metastatic breast cancer (BC). However, its utility for early detection of breast cancer is severely limited due to poor clinical sensitivity and specificity. The glycosylation of CA15-3 is known to be affected by BC, and therefore it mi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Terävä, Joonas, Tiainen, Leena, Lamminmäki, Urpo, Kellokumpu-Lehtinen, Pirkko-Liisa, Pettersson, Kim, Gidwani, Kamlesh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6658058/ https://www.ncbi.nlm.nih.gov/pubmed/31344060 http://dx.doi.org/10.1371/journal.pone.0219480

Ejemplares similares

Glycovariant-based lateral flow immunoassay to detect ovarian cancer–associated serum CA125
por: Bayoumy, Sherif, et al.
Publicado: (2020)

Diagnostic potential of nanoparticle aided assays for MUC16 and MUC1 glycovariants in ovarian cancer
por: Jain, Shruti, et al.
Publicado: (2022)

Lectins as potential tools for cancer biomarker discovery from extracellular vesicles
por: Islam, Md. Khirul, et al.
Publicado: (2023)

Primary breast cancer biomarkers based on glycosylation and extracellular vesicles detected from human serum
por: Terävä, Joonas, et al.
Publicado: (2021)

A Nanoparticle-Based Approach for the Detection of Extracellular Vesicles
por: Islam, Md. Khirul, et al.
Publicado: (2019)

The past and present of prostate cancer and its treatment and diagnostics: A historical review
por: Lehtonen, Miikka, et al.
Publicado: (2023)

Use of CA15-3 for screening breast cancer: An antibody-lectin sandwich assay for detecting glycosylation of CA15-3 in sera
por: Choi, Jae Woong, et al.
Publicado: (2018)

An etanercept O-glycovariant with enhanced potency
por: Biel, Thomas G., et al.
Publicado: (2022)

A 15-min non-competitive homogeneous assay for microcystin and nodularin based on time-resolved Förster resonance energy transfer (TR-FRET)
por: Akter, Sultana, et al.
Publicado: (2021)

Both comorbidity and worse performance status are associated with poorer overall survival after external beam radiotherapy for prostate cancer
por: Lehtonen, Miikka, et al.
Publicado: (2020)

Serum CA 15-3 assay in the diagnosis and follow-up of breast cancer.
por: Kallioniemi, O. P., et al.
Publicado: (1988)

Transcripts of the Prostate Cancer-Associated Gene ANO7 Are Retained in the Nuclei of Prostatic Epithelial Cells
por: Metsälä, Olli, et al.
Publicado: (2023)

Prognostic Impact of Elevation of Cancer Antigen 15-3 (CA15-3) in Patients With Early Breast Cancer With Normal Serum CA15-3 Level
por: Ryu, Jai Min, et al.
Publicado: (2023)

Lead Time and Prognostic Role of Serum CEA, CA19-9, IL-6, CRP, and YKL-40 after Adjuvant Chemotherapy in Colorectal Cancer
por: Lehtomäki, Kaisa, et al.
Publicado: (2021)

Adjuvant Capecitabine for Early Breast Cancer: 15-Year Overall Survival Results From a Randomized Trial
por: Joensuu, Heikki, et al.
Publicado: (2022)

High baseline Tie1 level predicts poor survival in metastatic breast cancer
por: Tiainen, Leena, et al.
Publicado: (2019)

Undergraduate curriculum in palliative medicine at Tampere University increases students’ knowledge
por: Lehto, Juho T., et al.
Publicado: (2017)

Troponin T-release associates with cardiac radiation doses during adjuvant left-sided breast cancer radiotherapy
por: Skyttä, Tanja, et al.
Publicado: (2015)

Dynamic Contrast-Enhanced Imaging as a Prognostic Tool in Early Diagnosis of Prostate Cancer: Correlation with PSA and Clinical Stage
por: Wu, Xingchen, et al.
Publicado: (2018)

3-Year Follow-Up of Radiation-Associated Changes in Diastolic Function by Speckle Tracking Echocardiography
por: Tuohinen, Suvi Sirkku, et al.
Publicado: (2021)

A graphical LASSO analysis of global quality of life, sub scales of the EORTC QLQ-C30 instrument and depression in early breast cancer
por: Poikonen-Saksela, Paula, et al.
Publicado: (2022)

Correlation of cancer antigen 15-3 (CA15-3) serum level and bony metastases in breast cancer patients
por: Fakhari, Ashraf, et al.
Publicado: (2019)

Multi-Angle Effector Function Analysis of Human Monoclonal IgG Glycovariants
por: Dashivets, Tetyana, et al.
Publicado: (2015)

Estimation of adequate setup margins and threshold for position errors requiring immediate attention in head and neck cancer radiotherapy based on 2D image guidance
por: Kapanen, Mika, et al.
Publicado: (2013)

ERBB4 Promoter Polymorphism Is Associated with Poor Distant Disease-Free Survival in High-Risk Early Breast Cancer
por: Kurppa, Kari J., et al.
Publicado: (2014)

Transient Changes in Serum CEA, CA19-9, CRP, YKL-40, and IL-6 during Adjuvant Chemotherapy and Survival of Patients with Colorectal Cancer
por: Lehtomäki, Kaisa, et al.
Publicado: (2023)

Long-term health-related quality of life of breast cancer survivors remains impaired compared to the age-matched general population especially in young women. Results from the prospective controlled BREX exercise study
por: Roine, Eija, et al.
Publicado: (2021)

Treatment accuracy without rotational setup corrections in intracranial SRT
por: Boman, Eeva, et al.
Publicado: (2016)

Does special education in palliative medicine make a difference in end-of-life decision-making?
por: Piili, Reetta P., et al.
Publicado: (2018)

Changes in attitudes towards hastened death among Finnish physicians over the past sixteen years
por: Piili, Reetta P., et al.
Publicado: (2018)

Physicians’ decreased tendency to choose palliative care for patients with advanced dementia between 1999 and 2015
por: Haapasalmi, Saila, et al.
Publicado: (2021)

Serum CA549 in primary breast cancer: comparison with CA15.3 and MCA.
por: Gion, M., et al.
Publicado: (1994)

Value of CA 15:3 in the follow-up of breast cancer patients.
por: Pons-Anicet, D. M., et al.
Publicado: (1987)

Diagnostic Value of Neuron-Specific Enolase (NSE) and Cancer Antigen 15-3 (CA 15-3) in the Diagnosis of Pleural Effusions
por: Saba, Mohammad Ali, et al.
Publicado: (2017)

Clinical utility of tumour marker velocity of cancer antigen 15–3 (CA 15–3) and carcinoembryonic antigen (CEA) in breast cancer surveillance
por: Hing, J.X., et al.
Publicado: (2020)

Decreases in TGF-β1 and PDGF levels are associated with echocardiographic changes during adjuvant radiotherapy for breast cancer
por: Aula, Hanna, et al.
Publicado: (2018)

Local and systemic oxidant/antioxidant status before and during lung cancer radiotherapy
por: Crohns, Marika, et al.
Publicado: (2009)

Transforming growth factor beta 1 levels predict echocardiographic changes at three years after adjuvant radiotherapy for breast cancer
por: Aula, Hanna, et al.
Publicado: (2019)

Radiotherapy-induced diffuse myocardial fibrosis in early-stage breast cancer patients – multimodality imaging study with six-year follow-up
por: Moisander, Mikko, et al.
Publicado: (2023)

ST2 levels increased and were associated with changes in left ventricular systolic function during a three-year follow-up after adjuvant radiotherapy for breast cancer
por: Aula, Hanna, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_tu4mrffi4pra25g3i8k46to72u